MarketCap
Facebook
X
TelegramQuarterly report 2023-Q3
added 11-08-2023
Invitae Corporation Total Shareholders Equity 2011-2026 | NVTA
Annual Total Shareholders Equity Invitae Corporation
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 102 M | 2.98 B | 1.98 B | 380 M | 162 M | 122 M | 99.1 M | 138 M | -83.6 M | -37.3 M | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 2.98 B | -83.6 M | 584 M |
Quarterly Total Shareholders Equity Invitae Corporation
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.08 B | -201 M | -36.7 M | 102 M | 159 M | 386 M | 2.84 B | 2.98 B | 3.11 B | 2.65 B | 2.38 B | 1.98 B | 1.98 B | 1.98 B | 1.98 B | 380 M | 380 M | 380 M | 380 M | 162 M | 162 M | 162 M | 162 M | 122 M | 122 M | 122 M | 122 M | 99.1 M | 99.1 M | 99.1 M | 99.1 M | 138 M | 138 M | 138 M | 138 M | -83.6 M | -83.6 M | -83.6 M | -83.6 M | -37.3 M | - | - | - | -12.8 M | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 3.11 B | -1.08 B | 595 M |
Total Shareholders Equity of other stocks in the Diagnostics research industry
| Issuer | Total Shareholders Equity | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
27.5 M | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
-48.2 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Bioventus
BVS
|
184 M | $ 8.96 | 1.01 % | $ 597 M |  USA |
 |
Brainsway Ltd.
BWAY
|
19.6 M | $ 13.67 | 0.15 % | $ 99.4 M |  Israel |
 |
Aspira Women's Health
AWH
|
6.73 M | - | -6.19 % | $ 10.5 M | USA |
 |
Castle Biosciences
CSTL
|
456 M | $ 25.94 | 0.43 % | $ 721 M | USA |
 |
DexCom
DXCM
|
2.75 B | $ 68.13 | 2.7 % | $ 26.6 B | USA |
 |
Charles River Laboratories International
CRL
|
3.16 B | $ 154.1 | 1.4 % | $ 7.64 B | USA |
 |
CareDx, Inc
CDNA
|
303 M | $ 17.47 | 0.87 % | $ 931 M | USA |
 |
Guardant Health
GH
|
-99.3 M | $ 88.35 | 1.34 % | $ 11.1 B | USA |
 |
Accelerate Diagnostics
AXDX
|
-22.3 M | - | -61.36 % | $ 2.46 M | USA |
 |
Exact Sciences Corporation
EXAS
|
2.4 B | $ 103.93 | 0.08 % | $ 19.6 B | USA |
 |
Global Cord Blood Corporation
CO
|
4.88 B | - | - | $ 399 M |  China |
 |
Genetic Technologies Limited
GENE
|
16.4 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
1.69 B | - | 0.12 % | $ 80.1 M | China |
 |
Fulgent Genetics
FLGT
|
1.13 B | $ 15.57 | 4.11 % | $ 471 M | USA |
 |
IQVIA Holdings
IQV
|
6.5 B | $ 168.8 | 2.43 % | $ 29 B | USA |
|
Biodesix
BDSX
|
20.9 M | $ 17.35 | 0.35 % | $ 2.25 B | USA |
 |
ICON Public Limited Company
ICLR
|
9.52 B | $ 99.75 | 2.19 % | $ 8.23 B |  Irlanda |
 |
Anixa Biosciences
ANIX
|
15.2 M | $ 2.86 | 0.7 % | $ 92.8 K | USA |
 |
Danaher Corporation
DHR
|
52.5 B | $ 195.49 | 2.14 % | $ 139 B | USA |
 |
Biocept
BIOC
|
8.86 M | - | -13.05 % | $ 7.29 M | USA |
 |
Heska Corporation
HSKA
|
422 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
5.39 M | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
2.37 B | $ 122.2 | 2.45 % | $ 19.4 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
7.17 B | $ 199.41 | 0.23 % | $ 22.1 B | USA |
 |
QIAGEN N.V.
QGEN
|
3.57 B | - | - | $ 10.6 B |  Niderland |
 |
Agilent Technologies
A
|
5.39 B | $ 113.82 | 1.78 % | $ 34.6 B | USA |
 |
BioNano Genomics
BNGO
|
35.4 M | $ 1.13 | 1.35 % | $ 1.44 M | USA |
 |
DarioHealth Corp.
DRIO
|
58.1 M | $ 9.02 | 7.13 % | $ 256 M | Israel |
 |
NeoGenomics
NEO
|
837 M | $ 8.31 | 0.85 % | $ 1.06 B | USA |
 |
Neogen Corporation
NEOG
|
2.07 B | $ 9.26 | 1.59 % | $ 2.01 B | USA |
 |
Lantheus Holdings
LNTH
|
1.09 B | $ 79.31 | 1.03 % | $ 5.35 B | USA |
 |
Pacific Biosciences of California
PACB
|
5.35 M | $ 1.42 | 4.04 % | $ 426 M | USA |
 |
Chembio Diagnostics
CEMI
|
17.8 M | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
-1.45 M | - | - | $ 9.42 M | Israel |
 |
Co-Diagnostics
CODX
|
86 M | $ 4.4 | 101.83 % | $ 129 M | USA |
 |
Medpace Holdings
MEDP
|
459 M | $ 454.33 | 0.15 % | $ 13.1 B | USA |
 |
Motus GI Holdings
MOTS
|
2.69 M | - | -34.28 % | $ 263 K | Israel |
 |
Mettler-Toledo International
MTD
|
-23.6 M | $ 1 219.09 | 1.66 % | $ 25.1 B |  Schweiz |
 |
Celcuity
CELC
|
116 M | $ 114.35 | -0.48 % | $ 4.51 B | USA |
 |
DermTech
DMTK
|
57.2 M | - | -11.32 % | $ 2.94 M | USA |
 |
National Research Corporation
NRC
|
14 M | $ 17.74 | 1.95 % | $ 397 M | USA |
 |
Enzo Biochem
ENZ
|
56.1 M | - | -8.98 % | $ 14.8 K | USA |
 |
Natera
NTRA
|
706 M | $ 200.3 | 1.33 % | $ 19.7 B | USA |
 |
OPKO Health
OPK
|
1.37 B | $ 1.2 | 0.42 % | $ 833 M | USA |